Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Cantor Fitzgerald
UBS
Merck
Chinese Patent Office
Dow
Federal Trade Commission
Chubb

Generated: December 14, 2018

DrugPatentWatch Database Preview

TOPICORT Drug Profile

« Back to Dashboard

When do Topicort patents expire, and when can generic versions of Topicort launch?

Topicort is a drug marketed by Taro Pharm Inds Ltd and Taro Pharms and is included in ten NDAs. There are three patents protecting this drug and one Paragraph IV challenge.

This drug has four patent family members in four countries.

The generic ingredient in TOPICORT is desoximetasone. There are seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the desoximetasone profile page.

Drug patent expirations by year for TOPICORT
Pharmacology for TOPICORT
Medical Subject Heading (MeSH) Categories for TOPICORT
Synonyms for TOPICORT
(11beta,16alpha)-9-Fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione
(1R,2S,10S,11S,13R,14S,15S,17S)-1-fluoro-17-hydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one
17-Deoxymethansone
17-Desoximethasone
382-67-2
382D672
4E07GXB7AU
9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione
9alpha-fluoro-11beta,21-dihydroxy-16alpha-methyl-1.4-pregnadiene-3,20-dione
9alpha-fluoro-16alpha-methyl-Delta(1)-corticosterone
A 41-304
A 41304
A-41-304
AB2000738
AC1NSJXQ
AKOS030254657
AS-15787
BDBM50103622
BRN 2228097
C-55186
CAS-382-67-2
CCG-101120
CHEBI:691037
CHEMBL1766
CS-3002
CTK8F9086
D03697
D0CZ1Q
DB00547
Deoxymethasone
Desossimetasone
Desossimetasone [DCIT]
Desoximetason
Desoximetasona
Desoximetasona [INN-Spanish]
desoximetasone
Desoximetasone (USP/INN)
Desoximetasone [USAN:USP:INN:BAN]
Desoximetasonum
Desoximetasonum [INN-Latin]
desoximethasone
Desoxymetasone
Desoxymethasone
DSSTox_CID_25647
DSSTox_GSID_45647
DSSTox_RID_81025
DTXSID3045647
EINECS 206-845-3
Esperson
Flubason
GTPL7067
HMS2052C15
HMS2236H07
HOE 304
HOE-304
HY-17570
Ibaril
MLS000028654
MLS001076073
MLS001424230
MolPort-003-941-111
NC00370
NCGC00023648-03
NCGC00023648-04
Opera_ID_52
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16-methyl-, (11beta,16alpha)-
Q-200938
Q790
R 2113
R-2113
SC-46986
SCHEMBL4214
SMR000058856
Stiedex
Topicort (TN)
Topicort Emollient (TN)
Topicort LP
Topisolon
Tox21_110889
Tox21_110889_1
UNII-4E07GXB7AU
VWVSBHGCDBMOOT-IIEHVVJPSA-N
ZINC4212854

US Patents and Regulatory Information for TOPICORT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm Inds Ltd TOPICORT desoximetasone CREAM;TOPICAL 073210-001 Nov 30, 1990 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd TOPICORT desoximetasone OINTMENT;TOPICAL 074286-001 Jun 7, 1996 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd TOPICORT desoximetasone GEL;TOPICAL 074904-001 Jul 14, 1998 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd TOPICORT LP desoximetasone CREAM;TOPICAL 018309-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharm Inds Ltd TOPICORT desoximetasone OINTMENT;TOPICAL 018763-001 Sep 30, 1983 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for TOPICORT
Drugname Dosage Strength RLD Date
➤ Subscribe Topical Spray 0.25% ➤ Subscribe ➤ Sign Up

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Healthtrust
Baxter
QuintilesIMS
Mallinckrodt
UBS
Merck
Fish and Richardson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.